February 5, 2015:
FORGE Life Science is awarded its third grant from the NIH National Institute for Allergy and Infectious Disease titled, “An Antiviral to Treat Progressive Multifocal Leukoencephalopathy (PML)” (1R43AI118232-01). Read more
Main Menu
- Home
- Management, Board Members and Advisors
- Platform & Pipeline
- Platform and Pipeline
- An-allosteric-inhibitor-of-sirtuin-2-blocks-hepatitis-B-virus
- An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity
- Evrys SIRT2 Modulator Promotes Death of HCMV-Infected Monocytes, August 2023”.
- Evrys SIRT2 Allosteric Modulator with Broad-Spectrum Antiviral Activity, June 2023”.
- EvrysBio Science Update at BioCentury 2025 Chicago
- Structural basis for sirtuin 2 activity and modulation: Current state and opportunities
- News
- Contact Us
- Evrys Bio Slide Deck
- Jobs
Evrys Bio
3805 Old Easton Road
Doylestown, PA 18902
Federal Conflict of Interest Policy Statement
